Clinical and morphological characteristics of infective endocarditis
https://doi.org/10.30629/0023-2149-2020-98-2-115-121
Abstract
The aim of the study was to identify the features of the clinical course and morphogenesis of infective endocarditis (IE) in HIVinfected injecting drug users with concomitant hepatitis C virus infection in comparison with the clinical and morphological picture of endocarditis in persons without drug dependence. It was found that the causative agent of IE in HIV-infected patients was staphylococcus aureus (71.8%), and in persons without drug dependence in the etiology of the disease the conditionally pathogenic flora prevailed. In HIV-infected drug-dependent patients, the tricuspid valve was affected (82.7%), and in persons without drug dependence — isolated aortic valve damage (40%) and combined mitral and aorticvalve lesions (36.4%). Purulent sepsis complications in drug-dependent patients with IE are less common than in patients without drug dependence due to immunosuppression, which is present in HIV-infected persons.
About the Authors
V. I. Ulanova
I.I. Mechnikov North-Western State Medical University
Russian Federation
Veronika I. Ulanova — MD, PhD, DSc, associate рrofessor of the Eichwald Department of therapy and rheumatology
191015, Saint Petersburg
Russian Federation
Veronika I. Ulanova — MD, PhD, DSc, associate рrofessor of the Eichwald Department of therapy and rheumatology
191015, Saint Petersburg
V. I. Mazurov
V.A. Almazov National Medical Research Center
Russian Federation
197341, Saint Petersburg
Russian Federation
197341, Saint Petersburg
V. A. Zinzerling
V.A. Almazov National Medical Research Center
Russian Federation
197341, Saint Petersburg
Russian Federation
197341, Saint Petersburg
References
1. Tyurin V.P., Dubinina S.V. Infectious endocarditis in elderly and senile persons. Klinicheskaya meditsina. 2003;4:53–6. (in Russian) [Тюрин В.П., Дубинина С.В. Инфекционный эндокардит у лиц пожилого и старческого возраста. Клиническая медицина. 2003;4:53‒6.]
2. Tazina S.Ya., Gurevich M.A. Modern infectious endocarditis. Klinicheskaya meditsina. 1999;12:19–23. (in Russian) [Тазина С.Я., Гуревич М.А. Современный инфекционный эндокардит. Клиническая медицина. 1999;12:19‒23.]
3. Mylonakis E., Calderwood S. Infective endocarditis in adults. N. Engl. J. Med. 2001;18(345):1318‒30.
4. Hoen B., Alla F., Selton-Suty C. et al. Changing profile of infective endocarditis. Results of 1-year survey in France. JAMA. 2002;288:75‒81.
5. Lopez J., Sevilla T., Vilacosta I., Garcia H., Sarria C., Pozo E. et al. Clinical significance of congestive heart failure in prosthetic valve endocarditis. A multicenter study with 257 patients. Rev. Esp. Cardiol. (Engl Ed). 2013;66:384–390.
6. Ho H.H., Siu C.W., Yiu K.H. et al. Prosthetic valve endocarditic in a multicenter registry of Chinese patients. Asian Cardiovasc. Thorac. Ann. 2010;18:430–4.
7. Keeshin S.W., Feinberg J. Endocarditis as a marker for new epidemics of injection drug use. Am. J. Med. Sci. 2016;352(6):609–14.
8. Athan E., Chu V.H., Tattevin P. et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307:1727–35.
9. Rundstrom H., Kennergren C., Andersson R. et al. Pace maker endocarditis during 18 years in Goteborg. Scand. J. Infect. Dis. 2004;36:674–9.
10. Baddour L.M., Cha Y.M., Wilson W.R. Clinical practice. Infections of cardiovascular implantable electronic devices. N. Engl. J. Med. 2012;367:842–9.
11. Corti V.E., Palmieri O.J., Villafane M.F. et al. Evaluation of 61 episodes of infective endocarditis in intravenous drug abusers and human immunodeficiency tipe-1 virus infection. Rev. Argent. Microbiol. 2004;36(2):85‒7.
12. Moss R., Munt B. Injecting drug use and right-sided endocarditis. Heart. 2003;89:577‒81.
13. Yanagawa B., Bahji A., Lamba W., Tan D.H., Cheema A., Syed I. et al. Endocarditis in the setting of IDU: multidisciplinary management. Curr. Opin. Cardiol. 2018;33(2):140–7.
14. Stein M.D., Maksad J., Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk, and willingness to receive treatment. Drug. Alcohol. Depend. 2001;61:211‒5.
15. Mathew J., Addai T., Anand A. et al. Clinical features, site of involvement, bacteriologic findings and outcome of infection endocarditis in intravenous drug users. Heart. 2008;155:1641‒8.
16. Miro J.M., Moreno A., Mestres C.A. Infective endocarditis in intravenous drug abusers. Curr. Infect. Dis. Rep. 2003;5(4):307‒16.
17. Yanagawa B., Bahji A., Lamba W., Tan D.H., Cheema A., Syed I. et al. Endocarditis in the setting of IDU: multidisciplinary management. Curr. Opin. Cardiol. 2018;33(2):140‒7.
18. Reyes M. P., Reyes K.S. Gram-negative endocarditis. Curr. Infect. Dis. Rep. 2008;10:267‒74.
19. Kugler K.C., Biedenbach D.J., Jones R.N. Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. Diag. Microbiol. Infect. Dis. 1999;34:73‒6.
20. Davis G.L., Rodrigue J.R. Treatment of chronic hepatitis C in active drug users. N. Engl. J. Med. 2001;3:215‒7.
21. Zhang C., Yang R., Xia X et al. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in southeast region of Yunnan, China. J. Acquir. Defic. Syndr. 2002;29 (2):191‒6.
22. Prendergast B.D. HIV and cardiovascular medicine. Heart. 2003;89: 793‒800.
23. Losa J.E., Miro J.M., Del Rio A. et al. Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin. Microbiol. Infect. 2003;6(1):45‒54.
24. Chang F. Y. Staphylococcus aureus bacteremia and endocarditis. J. Microbiol. Immunol. Infect. 2000;33(2):63‒8.
25. D’Amati G., DiGiola R.T., Gallo P. Pathological findings in HIV heart disease. Ann. NY. Acad. Sci. 2001;946:23‒45.
26. Garcia-Cabrera E., Fernandez-Hidalgo N., Almirante B., Ivanova-Georgieva R., Noureddine M., Plata A. et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127:2272–84.
27. Snygg-Martin U., Gustafsson L., Rosengren L., Alsio A., Ackerholm P. Andersson R. et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin. Infect. Dis. 2008;47:23–30.
28. Duval X., Iung B., Klein I., Brochet E., Thabut G., Arnoult F. et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann. Intern. Med. 2010;152:497–504.
29. Vasudev R., Shan P., Bikkina M., Shamoon F. Infective endocarditis in HIV. Int. J. Cardiol. 2016;;214:216‒17.
30. Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G., Tleyjeh I.M., Rybak M.J. et al. Infective Endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation. 2015;13;132(15):1435‒86.
Review
For citations:
Ulanova V.I., Mazurov V.I., Zinzerling V.A. Clinical and morphological characteristics of infective endocarditis. Clinical Medicine (Russian Journal). 2020;98(2):115-121. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-2-115-121
Views:
868
Email this article 